CM
SAGE

Caption Management’s Sage Therapeutics SAGE Stock Holding History

Caption Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$3.06K – 1788
2024
Q3 		$3.61K Hold
500
– – ﹤0.01% 1219
2024
Q2 		$5.43K Sell
500
-4,390
-90% -$56.3K ﹤0.01% 1099
2024
Q1 		$91.6K Buy
4,890
+1,820
+59% +$42K ﹤0.01% 1061
2023
Q4 		$66.5K Sell
3,070
-18,800
-86% -$373K ﹤0.01% 1207
2023
Q3 		$450K Buy
+21,870
New +$632K 0.01% 955
2022
Q3 		– Sell
-4,362
Closed -$141K – 1802
2022
Q2 		$141K Sell
4,362
-59,935
-93% -$2.01M ﹤0.01% 1268
2022
Q1 		$2.13M Sell
64,297
-2,324
-3% -$87.4K 0.03% 731
2021
Q4 		$2.83M Buy
+66,621
New +$2.79M 0.03% 662
2021
Q3 		– Sell
-139,600
Closed -$6.4M – 1761
2021
Q2 		$7.93M Buy
139,600
+128,770
+1,189% +$9.1M 0.1% 251
2021
Q1 		$810K Buy
+10,830
New +$888K 0.02% 725
2020
Q1 		– Sell
-65,300
Closed -$3.78M – 1047
2019
Q4 		$4.71M Buy
+65,300
New +$8.03M 0.16% 178
2019
Q2 		– Sell
-40,600
Closed -$6.93M – 799
2019
Q1 		$6.46M Buy
40,600
+17,750
+78% +$2.57M 0.36% 77
2018
Q4 		$2.19M Buy
+22,850
New +$2.62M 0.17% 170

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's SAGE Position: Q4 2024 in Review

Caption Management sold out of Sage Therapeutics (SAGE) in Q4 2024, closing a stake of 500 shares — an estimated $3.06K sold.

Caption Management first reported a position in SAGE in Q4 2018 and held it in 13 quarters. The position peaked at $7.93M in Q2 2021. 177 funds tracked by Wall St. Rank hold SAGE as of Q4 2024.

  • Caption Management reported no remaining Sage Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Caption Management sold 500 Sage Therapeutics shares in Q4 2024, an estimated $3.06K.
  • Caption Management first reported a position in Sage Therapeutics in Q4 2018 and held it in 13 quarters.
  • Caption Management's Sage Therapeutics position peaked at $7.93M in Q2 2021.
  • 177 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.